Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Trends in Pharmacological Sciences|January 18, 2022
Scratching the surface of itch receptorsRuchita Kothari, Xinzhong DongNeuron|January 29, 2026
The neuroimmune axis: Integrating two systems to decipher itchRuchita Kothari, Xinzhong DongThe Journal of Chemical Physics|October 3, 2019
An implicit lipid model for efficient reaction-diffusion simulations of protein binding to surfaces of arbitrary topologyYiben Fu, Osman N Yogurtcu, Ruchita Kothari, et al.Journal of Translational Medicine|May 23, 2026
Mast cell-specific receptor MrgprB2 selectively mediates oxaliplatin-induced neuropathic painLeo C Guan, Zhaoli Luo, Ruchita Kothari, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 17, 2023
Same-day versus staged revascularization of bilateral moyamoya arteriopathy in pediatric patientsRisheng Xu, Michael E Xie, Jennifer Kim, et al.Cell Chemical Biology|July 30, 2019
Bilirubin Links Heme Metabolism to Neuroprotection by Scavenging SuperoxideChirag Vasavda, Ruchita Kothari, Adarsha P Malla, et al.Science Signaling|May 10, 2022
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signalingChirag Vasavda, Evan R Semenza, Jason Liew, et al.Immunity|July 26, 2022
Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infectionXintong Dong, Nathachit Limjunyawong, Elizabeth I Sypek, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.Proceedings of the National Academy of Sciences of the United States of America|September 30, 2025
Biliverdin reductase A is a major determinant of protective NRF2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.Pageof 2